Recovery, desistance and 'coerced' drug treatment Tim McSweeney Senior Research Fellow Institute for - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Recovery, desistance and 'coerced' drug treatment Tim McSweeney Senior Research Fellow Institute for

Description:

Recovery, desistance and 'coerced' drug treatment' Tim McSweeney. Senior Research Fellow ... Assess extent to which one form of coerced' treatment in Britain ... – PowerPoint PPT presentation

Number of Views:96
Avg rating:3.0/5.0
Slides: 25
Provided by: timm150
Category:

less

Transcript and Presenter's Notes

Title: Recovery, desistance and 'coerced' drug treatment Tim McSweeney Senior Research Fellow Institute for


1
Recovery, desistance and 'coerced' drug
treatmentTim McSweeneySenior Research
FellowInstitute for Criminal Policy Research
2
What I want to do
  • Offer some definitions of recovery, desistance
    and coerced treatment
  • Consider why these issues are important?
  • Assess extent to which one form of coerced
    treatment in Britain contributes to these goals
    (relative to voluntary forms)?
  • overview use of DTTOs to date
  • present English evidence from a recent European
    study
  • Identify barriers that inhibit recovery and
    desistance

3
Definitions
  • No standard or universally agreed definitions
  • Coerced treatment - motivated, ordered or
    supervised by the CJS (Stevens et al., 2005)
  • Primary desistance (the achievement of a
    significant lull or cessation in offending) and
  • secondary desistance (an underlying change in
    self-identity wherein the ex-offender labels him
    or herself as such) Burnett and McNeill (2005)

4
Definitions
  • Recovery - special issue J Sub Abuse Treatment 33
    (3) 2007
  • sustained cessation or reduction in the
    frequency, quantity, and (high risk)
    circumstances of AOD use following a sustained
    period of harmful use or dependence
  • absence of, or progressive reduction in, the
    number and intensity of AOD-related problems and
  • evidence of enhanced global (physical, emotional,
    relational, educational/occupational) health
    (White, 2007)

5
Why are these issues important?
  • For theoretical, ethical and practical reasons
  • the factors associated with giving up drugs
    could be related to those associated with giving
    up crime (Gossop et al., 2005)
  • increasing shift from coercion (constrained
    choice) to outright compulsion (e.g. with testing
    on arrest) with allied concerns about
    net-widening, proportionality and effectiveness
    and
  • rapid expansion in range of CJ options targeting
    DUOs since 1997 (at considerable public expense -
    330m in 06/07).

6
How can coerced treatment contribute to these
goals?
  • Maguire Raynor (2006) state by acknowledging
    that
  • Recovery and desistance are processes not events
  • Access to timely appropriate support is key
  • Works required to develop motivation,
    opportunities and capacity to change
  • Agency is important in promoting/inhibiting
    change (thinking, attitudes, perceptions,
    identities, narratives, roles and
    responsibilities)
  • Tackling social problems and integration
    important too (housing, relationships,
    employability)
  • We need to provide opportunities to use new
    skills and roles

7
Does coerced treatment contribute to these
goals?
  • Focus here to DTTOs (suitable for north/south
    comparison)
  • 60,000 imposed in Britain since late 1990s
  • Incidence per 10,000 of the adult (16)
    population during 2006/07 was 1.7 in Scotland and
    3.6 in England and Wales
  • Between 2002-2005 in England and Wales
  • DTTO completion rates rose from 25 to 39 (now
    broadly consistent with Scottish orders and
    mainstream treatment)
  • 1-year reconviction rates for DTTOs fell from 79
    to 70 (reductions in frequency of offending too)
    (MoJ 2007 2008)

8
Does coerced treatment contribute to these
goals?
  • In British pilots those completing DTTOs
    significantly less likely to be reconvicted than
    those not (Hough et al., 2003 McIvor, 2004)
  • England 53 completers vs 91 non-completers
  • Scotland 52 completers vs 79 non-completers
  • Still marked regional variation in performance
    (in 2004/05)
  • 14 in Staffordshire and 15 in North Yorkshire
  • 53 in South London and 51 in Dorset.

9
Does coerced treatment contribute to these
goals?
  • Variations likely to be explained by
  • area-level differences in profile of those being
    sentenced
  • length of sentences being imposed (e.g. Dorset
    has tended to impose 6 month orders others also
    encouraged with DRRs)
  • treatment quality, availability and delivery
    (NAPO survey)
  • setting (whether community-based or residential)
  • treatment orientation (abstinence-based or
    controlled use)
  • responsiveness of interventions (e.g. to the
    needs of crack cocaine users) and
  • enforcement/breach practices (more flexibility in
    Scotland).

10
Recent evidence QCT Europe
  • Parallel studies in Austria, England, Germany,
    Italy and Switzerland. Also considered Dutch SOV
    pilots.
  • Sampled from 65 purposively selected treatment
    centres between June 2003 and May 2004 (mix of
    community-based and in-patient).
  • 845 people questioned using EuropASI at 4
    intervals.
  • 84 health and criminal justice professionals.
  • In-depth interviews with 138 subject to QCT.

11
QCT Europe English sample
  • 157 people recruited between June 2003 and
    January 2004.
  • Sampled from 10 purposively selected
    community-based treatment services in London and
    Kent.
  • Four-fifths in either day care (n66) only or
    in day care with a substitute prescription (n60)
    (only 4 of DTTO cases in England accessed rehab
    during this time).
  • 38 health and criminal justice professionals
    interviewed.
  • 57 in-depth interviews from quantitative sample
    serving a DTTO.

12
Those we interviewed (N157)
  • 89 (57) were in treatment as part of a DTTO.
  • Most (120) were male - average age 31 years.
  • 80 (125) described themselves as White.
  • 53 (82) left school before the age of 16.
  • 75 had neither worked nor studied in the 3 years
    prior to intake.
  • More than half (n83) experienced serious
    depression and anxiety in the past month.

13
Those we interviewed (N157)
  • Volunteers tended to report worse mental health
    problems.
  • 75 used heroin in month before intake 62
    crack 86 used heroin and crack.
  • 51 were injectors (last 6 months) 33 shared
    equipment
  • Nearly three-quarters (n111) previously treated
    for AOD dependency.
  • No difference in previous exposure to treatment
    between people on DTTOs and volunteers.

14
Those we interviewed (N157)
  • At intake, the English DTTO clients were
  • more likely to be male (plt0.001),
  • more likely to be homeless (plt0.01)
  • using a wider range of drugs (plt0.01) - including
    crack (plt0.001),
  • injecting more frequently (plt0.01),
  • spending more on drugs (plt0.001), and
  • were more criminally active (plt0.001).
  • Perhaps more to be gained if these people could
    be encouraged to stay and succeed in treatment?
    (cf. DTORS intake findings.)

15
The role of coercion
  • Across the entire QCT Europe sample of 845
    respondents
  • 65 of the volunteers reported some external
    pressure or duress to enter treatment
  • 22 of the QCT group reported experiencing no
    such pressures.
  • Link between legal status and perceived pressure
    but this does not reduce peoples motivation to
    change (Stevens et al., 2006). Again, supported
    by more recent DTORS intake findings.
  • People reported feeling less coercion during
    follow-up than at intake.

16
Key UK findings
  • Significant and sustained reductions in
    self-reported illicit drug use and offending
    behaviours over an 18-month follow-up period for
    both groups.

17
Average number of reported days involved in crime
during the last month
plt0.001
18
Average number of reported days using drugs
during the last month
excluding alcohol, cannabis and methadone
19
Key UK findings
  • Substantial reductions in reported expenditure on
    illicit drugs from a median of 1200 in the 30
    days before intake interview (n156) to 30
    (n104) at 6-month follow-up.
  • Modest improvements in mental health.
  • Reductions in reported risk behaviours (e.g.
    sharing injecting equipment).
  • Improvements in housing and personal
    relationships.
  • No change in (very high) rates of unemployment
    (78).
  • No significant differences between those
    coerced into drug treatment and the comparison
    group of volunteers in retention rates and
    other outcomes.

20
Caveats and limitations
  • Sampling and response bias
  • 52 of those offered treatment in the 10 sites
    were interviewed most didnt show or stay long
    enough
  • Attrition ranged from 68 (t2), 64 (t3) to 61
    (t4)
  • But 82 were re-interviewed at least once
    post-admission
  • Reductions maintained when adjustments made for
    missing data and time at reduced risk (e.g.
    imprisonment).
  • Relies on self-reports of behaviour
  • But shown to be reliable in other studies
    involving offenders (Farrell 2005) and drug users
    (Gossop et al 2006)
  • The possibility of a spontaneous improvement
    effect
  • How much of the change is attributable to
    treatment/formal intervention and how much
    self-change processes?

21
Conclusions
  • Coerced treatment can have comparable retention
    rates and outcomes to drug treatment entered
    through non-criminal justice routes.
  • The English results replicate those from the
    other four partner countries involved in the QCT
    Europe study.
  • The approach could be considered a viable
    alternative to imprisonment and a vehicle for
    initiating recovery and desistance processes
  • most problem drug users fail to sustain behaviour
    changes made while in custody (75 relapse rate
    in one recent UK study) and
  • non-custodial treatment alternatives are likely
    to be a more cost effective approach and have
    fewer detrimental effects.

22
Conclusions - Barriers to facilitating recovery
and desistance (in Britain)
  • Scope for improving methods of delivery
  • Refining referral and assessment processes
  • difficulties assessing motivation and identifying
    those likely to do well
  • exacerbated by pressure of targets and
    performance management culture.
  • Providing appropriate, responsive treatment
    options in a timely manner (more focus on
    stimulant users - who are over-represented in CJ
    caseloads, women, young people and BME groups).

23
Conclusions - Barriers to facilitating recovery
and desistance (in Britain)
  • Offering consistency around procedures for drug
    testing, court/status reviews and enforcing
    coerced conditions
  • aims rationale for frequency of testing,
    consequences of
  • failed tests and how tests compliment care
    plans
  • continuity, style and quality of interaction
    during reviews
  • limited scope for discretion in responding to
    non-compliance.
  • Ensuring effective arrangements for aftercare and
    reintegration are in place. Too often just an
    afterthought.
  • Limited capacity to tackle wider social
    environmental factors

24
AcknowledgementsThe European Commission for
funding the studyThe University of Kent and the
other partner countries and agencies involved in
QCT Europe Rowdy Margaret for the
opportunity to presentFurther details of the
Institute for Criminal Policy Research are
available at www.kcl.ac.uk/icprFor more
information about the QCT Europe study
visithttp//www.kent.ac.uk/eiss/projects/qcteuro
pe/index.html
Write a Comment
User Comments (0)
About PowerShow.com